Back
CytoSorbents Quote, Financials, Valuation and Earnings
Sponsored
CTSO
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
CTSO
CytoSorbents
Last Price:
1.19
Seasonality Move:
-0.13%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.CytoSorbents Price Quote
$1.19
+0.00 (+-3.25%)
(Updated: October 5, 2024 at 6:24 AM ET)
CytoSorbents Key Stats
Sell
38
CytoSorbents (CTSO)
is a Sell
Day range:
$1.18 - $1.25
52-week range:
$0.70 - $2.15
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.79
P/B ratio:
3.85%
Volume:
79.6K
Avg. volume:
95.7K
1-year change:
-29.88%
Market cap:
$64.5M
Revenue:
$31.1M
EPS:
$-0.53
How Much Does CytoSorbents Make?
-
How Much Are CytoSorbents's Sales Annually?
CTSO Revenues are $31.1M -
How Much Profit Does CytoSorbents's Make A Year?
CTSO net income is -$28.5M
Is CytoSorbents Growing As A Company?
-
What Is CytoSorbents's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is CytoSorbents's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CytoSorbents Stock Price Performance
-
Did CytoSorbents Stock Go Up Last Month?
CytoSorbents share price went up by 19.7% last month -
Did CTSO's Share Price Rise Over The Last Year?
CTSO share price fell by -29.88% over the past 1 year
What Is CytoSorbents 52-Week High & Low?
-
What Is CytoSorbents’s 52-Week High Share Price?
CytoSorbents has traded as high as $2.15 over the past 52 weeks -
What Is CytoSorbents’s 52-Week Low Share Price?
CytoSorbents has traded as low as $0.70 over the past 52 weeks
CytoSorbents Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CytoSorbents?
-
How Much Debt Does CytoSorbents Have?
Total long term debt quarterly is $13.7M -
How Much Cash Does CytoSorbents Have?
Cash and short term investments quarterly total is $8.5M -
What Is CytoSorbents’s Book Value Per Share?
Book value per share is 0.31
Is CytoSorbents Cash Flow Positive?
-
What Is CTSO Cash Flow From Operations?
Cash flow from operations (TTM) is -$21.2M -
What Is CytoSorbents’s Cash Flow From Financing?
Cash flow from financing (TTM) is $22.1M -
What Is CytoSorbents’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$640.5K
CytoSorbents Return On Invested Capital
-
Is Management Doing A Good Job?
CTSO return on invested capital is -94.73% -
What Is CytoSorbents Return On Assets?
ROA measures how assets are converting to revenues and is -50.3% -
What Is CTSO Return On Equity?
ROE is a measure of profitability and is -125.7%
CytoSorbents Earnings Date & Stock Price
-
What Is CytoSorbents's Stock Price Today?
A single share of CTSO can be purchased today for 1.19 -
What Is CytoSorbents’s Stock Symbol?
CytoSorbents trades on the nasdaq under the ticker symbol: CTSO -
When Is CytoSorbents’s Next Earnings Date?
The next quarterly earnings date for CytoSorbents is scheduled on November 8, 2024 -
When Is CTSO's next ex-dividend date?
CytoSorbents's next ex-dividend date is October 6, 2024 -
How To Buy CytoSorbents Stock?
You can buy CytoSorbents shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CytoSorbents Competitors
-
Who Are CytoSorbents's Competitors?
Below is a list of companies who compete with CytoSorbents or are related in some way:
CytoSorbents Dividend Yield
-
What Is CTSO Dividend Yield?
CytoSorbents’s dividend yield currently is 0% -
What Is CytoSorbents’s Payout Ratio?
CytoSorbents’s payout ratio is 0% -
When Did CytoSorbents Last Pay A Dividend?
The latest dividend pay date is October 6, 2024 -
What Is CytoSorbents’s Dividend Per Share?
CytoSorbents pays a dividend of $0.00 per share
CytoSorbents Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 17.95% |
Revenue: | 9.53% | 2.19% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 4.50 |
Upside from Last Price: | 279.75% |